ArticleCancers2025

The Real-World Impact of PARP Inhibitor Maintenance Therapy in High Grade Serous Tubo-Ovarian and Peritoneal Cancers.

Maryam Al-Ani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.